Raymond James Financial
GH icon

Raymond James Financial’s Guardant Health GH Stock Holding History

Raymond James Financial’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.6M Sell
337,197
-1,192
-0.4% -$130K 0.01% 935
2026
Q1 		$30M Buy
338,389
+9,757
+3% +$980K 0.01% 1193
2025
Q4 		$33.2M Sell
328,632
-1,261
-0.4% -$113K 0.01% 1091
2025
Q3 		$20.6M Buy
329,893
+97,294
+42% +$5.29M 0.01% 1392
2025
Q2 		$12.1M Buy
232,599
+169,110
+266% +$7.55M ﹤0.01% 1729
2025
Q1 		$2.7M Sell
63,489
-8,875
-12% -$383K ﹤0.01% 2777
2024
Q4 		$2.21M Buy
+72,364
New +$2.04M ﹤0.01% 2893

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Raymond James Financial's GH Position: Q2 2026 in Review

Raymond James Financial reduced its Guardant Health (GH) stake by 0.35% in Q2 2026, selling an estimated $130K and leaving 337,197 shares worth $50.6M. The position accounts for 0.01% of the portfolio, ranked #935.

Raymond James Financial first reported a position in GH in Q4 2024 and has held it in 7 quarters since. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Raymond James Financial held 337,197 shares of Guardant Health worth $50.6M as of Q2 2026.
  • Raymond James Financial sold 1,192 Guardant Health shares in Q2 2026, an estimated $130K.
  • Guardant Health made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #935 holding.
  • Raymond James Financial first reported a position in Guardant Health in Q4 2024 and has held it in 7 quarters since.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.